Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
2.93 %
$ 218 M
Market Cap
-14.91
P/E
FENC - OPERATING INCOME
Operating Income FENC - Fennec Pharmaceuticals Inc.
2.57 M
LAST VALUE
45.39%
2 YEAR CAGR
17.05%
5 YEAR CAGR
11.21%
10 YEAR CAGR